Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
Cell Reports. Medicine
|
October 5, 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe
|
June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Journal of Virology
|
April 7, 2025
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques
Elise G Viox, Jonathan Richard, Andres G Grandea, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity
|
August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe
|
December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
The American Journal of Pathology
|
February 19, 2018
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84
Lyne Gagnon, Martin Leduc, Jean-Francois Thibodeau, et al.
Nature Communications
|
December 1, 2025
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC
Jonathan Richard, Michael W Grunst, Ling Niu, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
Cell Reports. Medicine
|
October 5, 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2020
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Cell Host & Microbe
|
June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Journal of Virology
|
April 7, 2025
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques
Elise G Viox, Jonathan Richard, Andres G Grandea, et al.
Biorxiv : the Preprint Server for Biology
|
April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal Efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity
|
August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe
|
December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
The American Journal of Pathology
|
February 19, 2018
A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84
Lyne Gagnon, Martin Leduc, Jean-Francois Thibodeau, et al.
Nature Communications
|
December 1, 2025
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC
Jonathan Richard, Michael W Grunst, Ling Niu, et al.
Page
of 20